POL7080

DRUG4 trials

Sponsors

Polyphor Ltd.

Conditions

BronchiectasisHealthyLower Respiratory InfectionRenal ImpairmentVentilator Associated Pneumonia

Phase 1

Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment

CompletedNCT02110459

Polyphor Ltd.Renal Impairment

Start: 2013-04-30End: 2015-07-31Updated: 2016-06-17

DDI Study to Investigate Interaction Between Amikacin and POL7080

CompletedNCT02897869

Polyphor Ltd.Healthy

Start: 2016-04-30End: 2016-12-31Updated: 2017-02-01

Phase 2

Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia

CompletedNCT02096328

Polyphor Ltd.Lower Respiratory Infection, Ventilator Associated Pneumonia

Start: 2013-10-31End: 2016-12-31Updated: 2017-11-28

Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.

TerminatedNCT02096315

Polyphor Ltd.Bronchiectasis, Lower Respiratory Infection

Start: 2013-12-31End: 2015-11-30Target: 20Updated: 2017-02-01

Related Papers

Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment.

2018-08-2725 citations